Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4638 USD | +0.83% | +2.77% | -33.84% |
May. 10 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NORTHWEST BIOTHERAPEUTICS, INC. | Bio Therapeutic Drugs | +0.83% | +2.77% | -33.84% | -34.68% | +68.65% | 564M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- NWBO Stock
- Charts Northwest Biotherapeutics, Inc.
- Comparison Chart